PBH
Price
$78.58
Change
+$0.30 (+0.38%)
Updated
Jan 17 closing price
Capitalization
3.6B
18 days until earnings call
VTRS
Price
$11.30
Change
-$0.04 (-0.35%)
Updated
Jan 17 closing price
Capitalization
14.18B
44 days until earnings call
Ad is loading...

PBH vs VTRS

Header iconPBH vs VTRS Comparison
Open Charts PBH vs VTRSBanner chart's image
Prestige Consumer Healthcare
Price$78.58
Change+$0.30 (+0.38%)
Volume$200.61K
Capitalization3.6B
Viatris
Price$11.30
Change-$0.04 (-0.35%)
Volume$7.72M
Capitalization14.18B
PBH vs VTRS Comparison Chart
Loading...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PBH vs. VTRS commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBH is a Hold and VTRS is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (PBH: $78.58 vs. VTRS: $11.30)
Brand notoriety: PBH and VTRS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PBH: 74% vs. VTRS: 88%
Market capitalization -- PBH: $3.6B vs. VTRS: $14.18B
PBH [@Pharmaceuticals: Other] is valued at $3.6B. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBH’s FA Score shows that 1 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • PBH’s FA Score: 1 green, 4 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, PBH is a better buy in the long-term than VTRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBH’s TA Score shows that 3 TA indicator(s) are bullish while VTRS’s TA Score has 2 bullish TA indicator(s).

  • PBH’s TA Score: 3 bullish, 3 bearish.
  • VTRS’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, PBH is a better buy in the short-term than VTRS.

Price Growth

PBH (@Pharmaceuticals: Other) experienced а +6.19% price change this week, while VTRS (@Pharmaceuticals: Other) price change was -3.17% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.30%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was -9.85%.

Reported Earning Dates

PBH is expected to report earnings on May 01, 2025.

VTRS is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($14.2B) has a higher market cap than PBH($3.6B). VTRS has higher P/E ratio than PBH: VTRS (238.80) vs PBH (14.90). PBH YTD gains are higher at: 0.627 vs. VTRS (-9.237). VTRS has higher annual earnings (EBITDA): 3.52B vs. PBH (10.8M). VTRS has more cash in the bank: 1.18B vs. PBH (63.6M). PBH has less debt than VTRS: PBH (1.21B) vs VTRS (18.4B). VTRS has higher revenues than PBH: VTRS (15.4B) vs PBH (1.13B).
PBHVTRSPBH / VTRS
Capitalization3.6B14.2B25%
EBITDA10.8M3.52B0%
Gain YTD0.627-9.237-7%
P/E Ratio14.90238.806%
Revenue1.13B15.4B7%
Total Cash63.6M1.18B5%
Total Debt1.21B18.4B7%
FUNDAMENTALS RATINGS
PBH vs VTRS: Fundamental Ratings
PBH
VTRS
OUTLOOK RATING
1..100
6658
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
20
Undervalued
PROFIT vs RISK RATING
1..100
10100
SMR RATING
1..100
6191
PRICE GROWTH RATING
1..100
4559
P/E GROWTH RATING
1..100
341
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (20) in the null industry is somewhat better than the same rating for PBH (76) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew somewhat faster than PBH’s over the last 12 months.

PBH's Profit vs Risk Rating (10) in the Pharmaceuticals Other industry is significantly better than the same rating for VTRS (100) in the null industry. This means that PBH’s stock grew significantly faster than VTRS’s over the last 12 months.

PBH's SMR Rating (61) in the Pharmaceuticals Other industry is in the same range as VTRS (91) in the null industry. This means that PBH’s stock grew similarly to VTRS’s over the last 12 months.

PBH's Price Growth Rating (45) in the Pharmaceuticals Other industry is in the same range as VTRS (59) in the null industry. This means that PBH’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is somewhat better than the same rating for PBH (34) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew somewhat faster than PBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PBHVTRS
RSI
ODDS (%)
Bullish Trend 11 days ago
78%
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 11 days ago
63%
Momentum
ODDS (%)
N/A
Bearish Trend 11 days ago
56%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
54%
Bearish Trend 11 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
47%
Bearish Trend 11 days ago
61%
Advances
ODDS (%)
Bullish Trend 24 days ago
60%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
53%
Bearish Trend 13 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 11 days ago
61%
Aroon
ODDS (%)
Bearish Trend 11 days ago
40%
Bearish Trend 11 days ago
66%
View a ticker or compare two or three
Ad is loading...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MACGX15.420.24
+1.58%
Morgan Stanley Inst Discovery A
MLXIX31.660.21
+0.67%
Catalyst Energy Infrastructure I
RGAVX12.620.07
+0.56%
ClearBridge Global Infrastructure Inc A
VTMNX15.630.06
+0.39%
Vanguard Developed Markets Index Instl
JOHAX23.05-0.04
-0.17%
JOHCM International Select Investor

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+0.38%
PAHC - PBH
34%
Loosely correlated
-0.53%
IRWD - PBH
32%
Poorly correlated
-3.17%
SUPN - PBH
28%
Poorly correlated
-0.34%
VTRS - PBH
27%
Poorly correlated
-0.35%
EBS - PBH
26%
Poorly correlated
-0.90%
More

VTRS and

Correlation & Price change

A.I.dvisor tells us that VTRS and PRGO have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VTRS and PRGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-0.35%
PRGO - VTRS
33%
Poorly correlated
-0.08%
AMRX - VTRS
31%
Poorly correlated
-0.60%
SNDL - VTRS
30%
Poorly correlated
-1.11%
ALKS - VTRS
29%
Poorly correlated
-0.94%
AMPH - VTRS
28%
Poorly correlated
+0.11%
More